Literature DB >> 3469156

Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis.

J P Stahl, J Croize, M A Lefèbvre, J P Bru, A Guyot, D Leduc, J B Fourtillan, M Micoud.   

Abstract

Ofloxacin diffusion into cerebrospinal fluid (CSF) was evaluated in nine patients with bacterial meningitis. Patients were under treatment with i.v. amoxicillin (100 mg/kg/day), and during the first five days they were also given oral ofloxacin, 200 mg b.i.d. On days 2 and 5, blood and CSF samples were collected for assays by both HPLC and microbiological techniques. Samples were obtained 2 h (n = 2), 4 h (n = 1), 6 h (n = 2), 8 h (n = 2) and 12 h (n = 2) after the ofloxacin dose respectively. Concentration in CSF was 50 to 60% of that in serum and there was no significant difference between results with the two assay techniques.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3469156     DOI: 10.1007/BF01661286

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  4 in total

1.  The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

Review 2.  The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

3.  [Therapeutic prospects of new fluoroquinolones].

Authors:  A Bryskier; J F Chantot; P Veyssier
Journal:  Presse Med       Date:  1985-12-21       Impact factor: 1.228

4.  Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis.

Authors:  M Wolff; B Regnier; C Daldoss; M Nkam; F Vachon
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

  4 in total
  8 in total

Review 1.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 2.  Ofloxacin clinical pharmacokinetics.

Authors:  K C Lamp; E M Bailey; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 3.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of the newer antibacterial 4-quinolones.

Authors:  M Neuman
Journal:  Clin Pharmacokinet       Date:  1988-02       Impact factor: 6.447

Review 5.  Potential role of fluoroquinolones in the treatment of bacterial meningitis.

Authors:  J Modai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

6.  Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges.

Authors:  C A Gogos; T G Maraziotis; N Papadakis; D Beermann; D K Siamplis; H P Bassaris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-06       Impact factor: 3.267

7.  Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitis.

Authors:  J C Pioget; M Wolff; E Singlas; M J Laisne; B Clair; B Regnier; F Vachon
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 8.  Pharmacokinetic disposition of quinolones in human body fluids and tissues.

Authors:  F Sörgel; U Jaehde; K Naber; U Stephan
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.